The Boston-based company grew its team by 35 percent in the first quarter of 2022.
The company uses evidence-based software to provide treatment for mild cognitive impairment and Alzheimer’s disease.
New hires can expect to join teams that are serious about driving high-impact growth.
The company was developed inside of genetic engineering innovator Colossal Biosciences.
A leader at the storied pharmaceutical company shared how investing in talent powers pioneering advancements in digital science.
Find out how the companies that raised last month’s largest rounds plan to invest the fresh capital.
We're always looking for news.
